Related Experiment Video
Updated: Jun 24, 2026

Isolation and Identification of Extravascular Immune Cells of the Heart
Published on: August 23, 2018
The prevalence of Th17 cells in patients with dilated cardiomyopathy
1Department of Cardiology, Affiliated Hospital, Medical College, Qingdao University, Qingdao, China. anyi1201@yahoo.cn
Insights
This study found increased T helper 17 (Th17) cells and related cytokines in patients with dilated cardiomyopathy (DCM). These findings suggest Th17 cells play a role in DCM development.
Area of Science:
- Immunology
- Cardiology
- Autoimmune Diseases
Background:
- Dilated cardiomyopathy (DCM) is a chronic autoimmune disease.
- T helper 17 (Th17) cells are critical regulators of autoimmune and inflammatory responses.
Purpose of the Study:
- To investigate the potential involvement of Th17 cells in the pathogenesis of DCM.
- To compare Th17 cell frequencies and related cytokine levels in DCM patients versus healthy individuals.
Main Methods:
- Flow cytometry was used to quantify Th17 cell frequencies in peripheral blood.
- Enzyme-linked immunosorbent assay (ELISA) measured cytokine secretion (IL-17, IL-6, IL-23).
- Real-time PCR assessed the expression of the transcription factor RORgammat.
Main Results:
- DCM patients exhibited significantly higher peripheral Th17 cell frequencies compared to healthy blood donors (HBD).
- Elevated levels of IL-17, IL-6, and IL-23 cytokines were observed in DCM patients.
- Increased RORgammat expression was also noted in DCM patients, alongside a distinct sex-based cytokine profile.
Conclusions:
- Th17 cell activity is enhanced in individuals with DCM.
- These findings indicate a significant role for Th17 cells in the development of DCM.
Purpose:
Dilated cardiomyopathy (DCM) is a chronic disease characterized by autoimmunity. Th17 cells are a distinct subset from Th1 and Th2 cells and play crucial regulatory functions in inflammatory and autoimmune processes. The current study was designed to investigate the possible involvement of Th17 cells in DCM.
Methods:
Th17 cells were detected in blood from DCM subjects and healthy blood donors using several methods including Th17 frequencies by flow cytometric analysis, cytokine (IL-17, IL-6 and IL-23) secretion by enzyme-linked immunosorbent assay and key transcription factor (RORgammat) by real time-PCR.
Results:
Patients with DCM demonstrated increased peripheral Th17 cells (2.2+/-1.2% vs 0.4+/-0.3%,P < 0.01), Th17 related cytokines (IL-17: 62.7+/-22.8 vs 15.6+/-8.6pg/ml, IL-6: 40.7+/-16.6 vs 10.9+/-5.3pg/ml, IL-23: 210.7+/-89.9 vs 90.6+/-38.8pg/ml, P < 0.01) and RORgammat (24.6+/-6.5 vs 3.2+/-1.1,P < 0.01) compared with healthy blood donors (HBD). Furthermore, there was a consistent differential sex-defined cytokine profile. Males showed higher frequencies of IL-17, IL-6 and IL-23 than females (IL-17: 70.7+/-20.7 vs 54.7+/-22.2pg/ml, P < 0.01; IL-6: 46.0+/-18.2 vs 35.4+/-13.0pg/ml, P < 0.05; IL-23: 238.1+/-106.2 vs 183.4+/-60.2pg/ml, P < 0.05) in patients with DCM .
Conclusion:
Th17 function is increased in patients with DCM, suggesting a role for Th17 cells in the pathogenesis of DCM.
Related Concept Videos
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Myocarditis I: Introduction
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy I: Introduction and Classification
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

